Coordinator of ASCIR (active suspensions), participant in Spin-NANO, OMT, HOT (optomechanical technologies), QuESTech (quantum electronics), and coordinator of DIVI (light-driven carrier dynamics).
UNIVERSITAT KONSTANZ
German research university strong in active matter physics, chemical biology, toxicology, and open science infrastructure, with 10+ ERC/MSCA grants.
Their core work
Universität Konstanz is a German research university with particular strength in fundamental physics, chemical biology, and mathematical sciences, consistently attracting prestigious ERC and MSCA grants. Their research spans active matter physics and optomechanical technologies, natural product synthesis and riboswitch biochemistry, toxicology and chemical safety assessment, and multilingualism studies. They also play a significant role in European open science infrastructure through the OpenAIRE initiative. The university bridges fundamental science with applied questions in health, safety, and societal challenges, making them a versatile research partner across disciplines.
What they specialise in
Coordinator of RiboDisc (riboswitch ligand discovery), ANaPSyS (natural products system synthesis), and SPICE (in-vivo spectroscopy); participant in ALFF (algal microbiome).
Major participant in EU-ToxRisk (EUR 1.4M, mechanism-based toxicity testing), partner in in3 (animal-free safety assessment), with recent keywords pointing to endocrine disruptors and adverse outcome pathways.
Participant in OpenAIRE2020 and OpenAIRE-Advance, contributing to European open access monitoring and open scholarship infrastructure.
Coordinator of MultiMind (the multilingual mind, bilingualism, migration), participant in DLEDA (democratization in Africa), Co-VAL (public administration), and coordinator of Goal Attribution in Groups.
Recent-period keywords include semi-definite programming, convex algebraic geometry, sum of squares, and real algebraic geometry, indicating a growing research line in computational mathematics.
How they've shifted over time
In the early H2020 period (2015–2018), Konstanz focused on open access research infrastructure, algal biotechnology, and foundational systems toxicology — reflecting a mix of infrastructure-building and basic biological research. From 2019 onward, the focus shifted markedly toward mathematical optimization (semi-definite programming, convex algebraic geometry), computational toxicology with regulatory impact (endocrine disruptors, adverse outcome pathways, in silico tools), and continued strength in condensed matter physics. This trajectory shows a university moving from descriptive and infrastructure-oriented work toward more computationally intensive and application-oriented research.
Konstanz is increasingly combining mathematical and computational methods with applied safety and toxicology questions, making them a strong partner for projects requiring rigorous quantitative approaches to regulatory science.
How they like to work
With 22 projects as coordinator (35%) and 40 as participant, Konstanz is comfortable both leading and contributing — a balanced profile typical of a strong mid-size research university. Their 521 unique partners across 42 countries indicate they are a well-connected hub rather than a repeat-partner institution. They work across consortium sizes, from intimate ERC teams to large RIA consortia like EU-ToxRisk and OpenAIRE, suggesting adaptability and an established reputation that attracts diverse invitations.
Konstanz has collaborated with 521 unique partners across 42 countries, placing it among the most broadly connected mid-size German universities in H2020. Their network spans well beyond the EU, with projects touching Africa (DLEDA) and broad international cooperation themes.
What sets them apart
Konstanz stands out for its unusual breadth: few universities of its size combine world-class physics (ERC-funded active matter, optomechanics) with deep chemical biology expertise AND contributions to European open science infrastructure. Their 10 ERC and MSCA grants signal individual researcher excellence rather than institutional volume-chasing. For consortium builders, this means access to highly specialized principal investigators who bring both scientific depth and experience navigating EU project management.
Highlights from their portfolio
- SPICELargest coordinated project (EUR 1.99M, 2018–2024) combining in-vivo spectroscopy with nano-structural labelling — a flagship for Konstanz's chemical biology strength.
- EU-ToxRiskTheir largest single funding allocation (EUR 1.41M) in a major European toxicology flagship, positioning Konstanz as a key player in mechanism-based safety science.
- ASCIRLong-running ERC-funded project (2016–2023, EUR 1.82M) on active suspensions with controlled interaction rules, representing their core physics expertise at its most ambitious.